The University of Southampton
University of Southampton Institutional Repository

Antimicrobial peptides derived from the human bactericidal/permeability-increasing protein (BPI) : structural determinants and mechanism of action

Antimicrobial peptides derived from the human bactericidal/permeability-increasing protein (BPI) : structural determinants and mechanism of action
Antimicrobial peptides derived from the human bactericidal/permeability-increasing protein (BPI) : structural determinants and mechanism of action

Bactericidal/Permeability-Increasing protein (BPI) is a 456 residue cationic protein from human neutrophils that binds with high affinity ot lipopolysaccharide (LPS) and specifically kills Gram-negative bacteria. Both of these properties of BPI are found in a proteolytic fragment corresponding to the amino-terminal portion of the protein, however, the precise mechanism of bactericidal activity of BPI is still unknown. Studies indicate that peptides containing residues 86-104 of BPI are sufficient for antibacterial activity and that these peptides are also able to kill Gram-positive bacteria.

Peptides were synthesised which contained amino acid residues 90-99 and flanking regions of BPI. Of these, peptide P2 (SKISGKWKAQKRFLKMSGNFGC) was used to study the physiological effects of peptide interaction with Escherichia coli ML35. The effect of P2 on macromolecular synthesis, colony-forming ability, cytoplasmic membrane (CM) and other membrane (OM) permeabilisation were studied concurrently so that they could be placed in chronological order. The growth-phase of E. coli was found to be important for the chronology of events: in exponential-phase E. coli ML35 (108 cells/ml) treated with P2 (50 μg/ml), the OM became permeabilised and O2-consumption stopped within minutes of peptide addition. Within 15 minutes, the CM was permeabilised and macromolecular synthesis stopped. With stationary-phase bacteria, the OM was permeabilised and O2-consumption stopped within 5 minutes of peptide addition; but, in contrast to exponential-phase cells, permeabilisation of the CM occurred much later, approximately 30 minutes following peptide addition. Cessation of O2-consumption was one of the earliest measurable effects of P2 on E. coli. Studies using different carbon sources showed that the presence of formate or certain other carbon sources, prevented this effect and also rescued E. coli form the antibacterial effects of P2. Further work indicated that formate dehydrogenase O or N were involved in the formate-dependant rescue, although the full reason for this phenomenon is not yet fully understood.

University of Southampton
Barker, Helen Claire
Barker, Helen Claire

Barker, Helen Claire (1997) Antimicrobial peptides derived from the human bactericidal/permeability-increasing protein (BPI) : structural determinants and mechanism of action. University of Southampton, Doctoral Thesis.

Record type: Thesis (Doctoral)

Abstract

Bactericidal/Permeability-Increasing protein (BPI) is a 456 residue cationic protein from human neutrophils that binds with high affinity ot lipopolysaccharide (LPS) and specifically kills Gram-negative bacteria. Both of these properties of BPI are found in a proteolytic fragment corresponding to the amino-terminal portion of the protein, however, the precise mechanism of bactericidal activity of BPI is still unknown. Studies indicate that peptides containing residues 86-104 of BPI are sufficient for antibacterial activity and that these peptides are also able to kill Gram-positive bacteria.

Peptides were synthesised which contained amino acid residues 90-99 and flanking regions of BPI. Of these, peptide P2 (SKISGKWKAQKRFLKMSGNFGC) was used to study the physiological effects of peptide interaction with Escherichia coli ML35. The effect of P2 on macromolecular synthesis, colony-forming ability, cytoplasmic membrane (CM) and other membrane (OM) permeabilisation were studied concurrently so that they could be placed in chronological order. The growth-phase of E. coli was found to be important for the chronology of events: in exponential-phase E. coli ML35 (108 cells/ml) treated with P2 (50 μg/ml), the OM became permeabilised and O2-consumption stopped within minutes of peptide addition. Within 15 minutes, the CM was permeabilised and macromolecular synthesis stopped. With stationary-phase bacteria, the OM was permeabilised and O2-consumption stopped within 5 minutes of peptide addition; but, in contrast to exponential-phase cells, permeabilisation of the CM occurred much later, approximately 30 minutes following peptide addition. Cessation of O2-consumption was one of the earliest measurable effects of P2 on E. coli. Studies using different carbon sources showed that the presence of formate or certain other carbon sources, prevented this effect and also rescued E. coli form the antibacterial effects of P2. Further work indicated that formate dehydrogenase O or N were involved in the formate-dependant rescue, although the full reason for this phenomenon is not yet fully understood.

This record has no associated files available for download.

More information

Published date: 1997

Identifiers

Local EPrints ID: 463150
URI: http://eprints.soton.ac.uk/id/eprint/463150
PURE UUID: c1823a98-5cb5-4cd5-a017-dfbe1ca6e01b

Catalogue record

Date deposited: 04 Jul 2022 20:46
Last modified: 04 Jul 2022 20:46

Export record

Contributors

Author: Helen Claire Barker

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×